The cerebellum is the largest brain structure in the posterior fossa. However, cerebellar infarcts were understudied up to the 1980s. Now well shown by CT and MRI scans, we can distinguish between territorial infarcts - involving the full territory of a cerebellar artery or its branches - and borderzone infarcts. This can help to predict the vascular mechanisms of the ischemia. Territorial infarcts have a thrombo-embolic mechanism. Cardiac embolism is the most frequent. Artery-to-artery embolism, atherosclerotic disease of the vertebral artery (mainly in its intracranial part) or basilar artery, and vertebral artery dissection come next. Among them, the importance of intra-arterial embolism from vertebral artery origin disease deserves to be evaluated in the future because of the therapeutic implications. Borderzone or endzone infarcts may have a hemodynamic mechanism or be due to small emboli. The most frequent cause is occlusion of the vertebral or basilar arteries, either due to atheroma or embolism; small or end (pial) artery disease comes next, due to hypercoagulability states (e.g. thrombocythemia, polycythemia, disseminated intravascular coagulation), arteries or intracranial atheroma; systemic hypotension is seldom found. The new neuroimaging methods for the assessment of intracranial hemodynamics (transcranial Doppler, magnetic resonance angiography, positron emission tomography and single photon emission computed tomography) provide future opportunities for a better study of these patients and the natural history of these lesions, and for a better definition of the role of various therapies and revascularization procedure.

Keywords:
Cerebellum, Cerebellar infarction, Cerebral infarction, Vertebrobasilar insufficiency
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.